Last reviewed · How we verify

NCT03518411: UP

Adaptation of the One-session CBT Protocol for Prevention of Mental Illness for Brazilian Portuguese

Status unknown NA Last updated 8 May 2018
What this trial tests

NA trial testing Cognitive Behavioral Therapy in Mental Disorder in 62 participants. Status unknown.

Timeline
1 December 2017
Primary endpoint
30 June 2018
30 November 2018

Quick facts

Lead sponsorMariane Bagatin Bermudez
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment62
Start date1 December 2017
Primary completion30 June 2018
Estimated completion30 November 2018
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Mariane Bagatin Bermudez

Who can join

18 and older, any sex, with Mental Disorder or CBT. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Recruitment of medicine students of federal university. 2. Psychiatric interview (MINI) and sclaes application. 3. Protocol of CBT 4. Scales and MINI will be applied at the times of 7, 30 and 90 days after the end of the therapy. 5. Statistical analysis

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Improved quality of life and reduced depressive symptoms in medical students after a single-session intervention.
    Bermudez MB, Costanzi M, Macedo MJA, Tatton-Ramos T, et al · · 2020 · cited 11× · PMID 31859792 · DOI 10.1590/1516-4446-2019-0526

Verify or expand the search:

Other trials of Cognitive Behavioral Therapy

Trials testing the same drug.

Other recruiting trials for Mental Disorder

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03518411.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing